ERYTHROPOIETIN ENHANCES IMMUNOGLOBULIN PRODUCTION AND PROLIFERATION BY HUMAN PLASMA-CELLS IN A SERUM-FREE MEDIUM

被引:19
作者
KIMATA, H
YOSHIDA, A
ISHIOKA, C
MIKAWA, H
机构
[1] Department of Pediatrics, Faculty of Medicine, Kyoto University Hospital, Kyoto
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1991年 / 59卷 / 03期
关键词
D O I
10.1016/0090-1229(91)90044-B
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of recombinant human erythropoietin (Epo) on plasma cells was studied in a serum-free medium, COSMEDIUM-001 (Cosmedium). Epo enhanced both Ig production and thymidine uptake by human plasma cell lines, AF-10 and IM-9. Interleukin-6 (IL-6) enhanced both Ig production and thymidine uptake by AF-10 and IM-9, while other cytokines, including IL-1β, IL-2, IL-3, IL-4, IL-5, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-α (IFN-α), or IFN-γ, failed to do so. However, the Epo effect was specific since Epo-induced enhancement of Ig production and thymidine uptake was blocked by the anti-Epo antibody but not by the anti-IL-6 antibody or the control antibody. Conversely, IL-6-induced enhancement was blocked by the anti-IL-6 antibody but not by the anti-Epo antibody. Epo also enhanced Ig production (IgG, IgM, and IgA) and thymidine uptake by PCA-1+ plasma cells generated in vitro. This enhancement was also blocked by the anti-Epo antibody but not by the anti-IL-6 antibody. Taken together, these results suggest that Epo enhances plasma cell responses by a different mechanism than does IL-6. © 1991.
引用
收藏
页码:495 / 501
页数:7
相关论文
共 20 条
[1]   ERYTHROPOIETIN HAS A MITOGENIC AND POSITIVE CHEMOTACTIC EFFECT ON ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LEE, ES ;
KESSIMIAN, N ;
LEVINSON, R ;
STEINER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5978-5982
[2]  
ANDERSON KC, 1989, BLOOD, V73, P1915
[3]  
ANDERSON KC, 1983, J IMMUNOL, V130, P1132
[4]   INTERLEUKIN-3 AND INTERLEUKIN-6 SYNERGISTICALLY PROMOTE THE PROLIFERATION AND DIFFERENTIATION OF MALIGNANT PLASMA-CELL PRECURSORS IN MULTIPLE-MYELOMA [J].
BERGUI, L ;
SCHENA, M ;
GAIDANO, G ;
RIVA, M ;
CALIGARISCAPPIO, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :613-618
[5]  
BOWEN DT, 1990, EUR J HAEMATOL, V44, P30
[6]  
CHRISTENSEN RD, 1989, BLOOD, V74, P917
[7]  
JELINEK DF, 1988, J IMMUNOL, V141, P164
[8]   AUTOCRINE GENERATION AND REQUIREMENT OF BSF-2/IL-6 FOR HUMAN MULTIPLE MYELOMAS [J].
KAWANO, M ;
HIRANO, T ;
MATSUDA, T ;
TAGA, T ;
HORII, Y ;
IWATO, K ;
ASAOKU, H ;
TANG, B ;
TANABE, O ;
TANAKA, H ;
KURAMOTO, A ;
KISHIMOTO, T .
NATURE, 1988, 332 (6159) :83-85
[9]  
KAWANO M, 1989, BLOOD, V73, P2145
[10]   HUMAN NATURAL-KILLER (NK) CELLS PRODUCE A LATE-ACTING B-CELL DIFFERENTIATION ACTIVITY [J].
KIMATA, H ;
SHERR, EH ;
SAXON, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (05) :381-389